RESEARCH
[Publication] Neuromodulation by the immune system: implications for brain-directed immunotherapy
July 28, 2025
Credits: WPI-Bio2Q
Co-authored by a Bio2Q researcher, this Review explores how the brain-immune axis acts as a key regulator of brain function and behavior through direct interactions with neural circuits. This work highlights how immunotherapies targeting neuroimmune pathways may offer therapeutic potential for psychiatric and neurological conditions.
| Title | Neuromodulation by the immune system: implications for brain-directed immunotherapy |
|---|---|
| Authors | Daniel H Cho [1],[2], Jun R Huh [3], [4],[5], Gloria B Choi [1],[2] |
| Short Description | This Review article, co-authored by a Bio2Q researcher, explores the growing recognition of the brain-immune axis as an important modulator of brain function and behavior, challenging the traditional view of the brain as immunologically isolated. This piece highlights how immune molecules, including cytokines and chemokines, influence neural activity, learning, memory, social behavior, and stress responses. The authors discuss the therapeutic potential of immunomodulatory approaches for neurological and psychiatric conditions, drawing on evidence from both animal models and clinical studies. This Review emphasizes recent findings that show immune signaling is a compelling target for brain-directed immunotherapy, and will provide a valuable resource that can be used to guide future research in neuroimmunology. |
| DOI | https://doi.org/10.1016/j.coi.2025.102568. |
| Journal | Current Opinion in Immunology |
| Vol/Num/Page | Volume 95, 102568 |
| Publication Date | 2025 June 6. |
Affiliations:
[1] Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA
[2] Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
[3] Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
[4] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan
[5] Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA, USA
SHARE
More Bio2Q News
[Publication]M cell–dependent commensal uptake confers encephalitogenic phenotyp...
Co-authored by researchers from Bio2Q and Keio University, and published in Proceedings of the National Academy of Sciences (PNAS), this stu...
【Seminar Report】WPI-Bio2Q Open Seminar
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held a seminar as follows. 17:00 -18:00 January 7, 2026 V...
[Publication]Niche-preserving transplantation promotes functional engraftment of...
Co-authored by Bio2Q and Keio University researchers, this study demonstrates a niche-preserving transplantation strategy that enables highl...
WPI-Bio2Q Newsletter "Bio2Q Connect" Vol. 2, Issue 12 Released
WPI-Bio2Q has released the latest issue of our newsletter, "Bio2Q Connect" (Vol. 2, Issue 12). This issue highlights the selection of six...
【Seminar】 WPI-Bio2Q Open Seminar: Tomoe Ishikawa, Ph.D.（for Keio Members）
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty...
